Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF

Biochem Biophys Res Commun. 1997 Jul 9;236(1):79-82. doi: 10.1006/bbrc.1997.6909.

Abstract

p21(Waf1/Cip1) is one of the key regulatory proteins in cell cycle, terminal differentiation, and apoptosis. Its promoter was shown to be transactivated by the wild-type p53 protein as well as in a p53-independent manner. In this report, we demonstrate that E1AF, an ets-related transcription factor, activates the human p21(Waf1/Cip1) promoter by interacting with the ets-binding sites located close to the two previously identified p53-responsive elements. Northern blot analysis revealed that p21(Waf1/Cip1) and E1AF were correlatively upregulated in response to cisplatin treatment in SiHa cells. Transient expression assays demonstrated that E1AF can activate the p21(Waf1/Cip1) promoter-driven luciferase reporter gene in SiHa cells. The p21(Waf1/Cip1) promoter activity was also increased in p53-null Saos2 osteosarcoma cells, but was markedly reduced when the ets-binding sites were deleted. These results indicate that E1AF positively regulates transcription from the p21(Waf1/Cip1) promoter in response to genotoxic stresses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenovirus E1A Proteins / genetics*
  • Antineoplastic Agents / pharmacology*
  • Cell Line
  • Cisplatin / pharmacology*
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / genetics*
  • Gene Expression Regulation / drug effects*
  • Humans
  • Promoter Regions, Genetic / genetics*
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-ets
  • Transcription Factors / genetics

Substances

  • Adenovirus E1A Proteins
  • Antineoplastic Agents
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • ETV4 protein, human
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ets
  • Transcription Factors
  • Cisplatin